trial

Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls

NCTId NCT01214005
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 60 (actual)
Sponsored by Brown University
Primary completion 2012-02
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2009-06
Primary completion
2012-02
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
smoking abstinence

Sponsors

Brown UniversityLead Sponsor

Investigators

1
Jennifer Tidey, Ph.D.Principal Investigator

Sites

1 total
Providence, United States

Linked catalysts

1
Smoking Abstinence and Lapse Effects in Smokers With Schizophrenia and Controls — primary completion2012-02

Facts & assertions

4 sourced
Enrollment
60
Phase
PHASE2
Primary Completion Date
2012-02
Status
COMPLETED
relationships
The graph out of here
drug
smoking abstinence
drug
lead_sponsor
Brown University
company
indication
Tobacco Use Disorder
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Jennifer Tidey, Ph.D.
person